ASCO 2021 Lung Caner – Luis G. Paz-Ares

Luis G. Paz-Ares explains which notable developments are taking place in the field of small-cell lung cancer with respect to new targets and targeted agents, how chemotherapeutic standards will change in the management of patients with small-cell lung cancer and highlights the most relevant findings presented at ASCO 2021 in terms of targeted therapies.

Here is the full ASCO 2021 Lung Cancer report.

More posts

Load More Posts